Spinal Cord Stimulation Devices Market

A Spinal Cord Stimulator (SCS) or Dorsal Column Stimulator (DCS) is a type of implantable neuromodulation device (sometimes called a "pain pacemaker") that is used to send electrical signals to select areas of the spinal cord (dorsal columns) for the treatment of certain pain conditions. SCS is a consideration for people who have a pain condition that has not responded to more conservative therapy.
Spinal Cord Stimulation Devices Market contains market size and forecasts of Spinal Cord Stimulation (SCS) Devices in global, including the following market information:
Global Spinal Cord Stimulation (SCS) Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Spinal Cord Stimulation (SCS) Devices Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Spinal Cord Stimulation (SCS) Devices companies in 2021 (%)
The global Spinal Cord Stimulation (SCS) Devices market was valued at 2555.9 million in 2021 and is projected to reach US$ 3924.1 million by 2028, at a CAGR of 6.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Rechargeable SCS Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Spinal Cord Stimulation (SCS) Devices include Medtronic, Boston Scientific, Abbott (St. Jude Medical), Nevro and Nuvectra, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Spinal Cord Stimulation (SCS) Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Spinal Cord Stimulation (SCS) Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Spinal Cord Stimulation (SCS) Devices Market Segment Percentages, by Type, 2021 (%)
Rechargeable SCS
Non-Rechargeable SCS
Global Spinal Cord Stimulation (SCS) Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Spinal Cord Stimulation (SCS) Devices Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgery Centers
Global Spinal Cord Stimulation (SCS) Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Spinal Cord Stimulation (SCS) Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Spinal Cord Stimulation (SCS) Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Spinal Cord Stimulation (SCS) Devices revenues share in global market, 2021 (%)
Key companies Spinal Cord Stimulation (SCS) Devices sales in global market, 2017-2022 (Estimated), (Units)
Key companies Spinal Cord Stimulation (SCS) Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Boston Scientific
Abbott (St. Jude Medical)
Nevro
Nuvectra